Viridian Therapeutics Inc

The current institutional shareholding score of Viridian Therapeutics Inc is 10.00, ranking 1 out of 388 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 112.73%, representing a quarter-over-quarter increase of 8.27%. The largest institutional shareholder is Steven Cohen, holding a total of 365.59K shares, representing 0.32% of shares outstanding, with 9.44% increase in holdings.